On the contrary, as an EGX holder I'm disappointed (naturally of course) that we're not getting a higher bid.
Given the recent acquisitions in the antibody field:
Feb 06 – Abgenix acquired by Amgen – US$2,200 million
May 06 – Cambridge Antibody Technology acquired by Astra Zeneca –
US$1,300 million
July 06 – Amrad/Zenyth acquired by CSL - A$108 million
Dec 06 - Domantis acquired by GSK – US$454 million
April 07 – Morphotek acquired by Eisai – US$325 million
I don't know enough to compare EGX to the above but it must be comparable to Amrad/Zenyth.
- Forums
- ASX - By Stock
- PTD
- merger announcement
PTD
unknown
merger announcement, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)